Neurotrophic factors are considered as part of the therapeutic strategy for neurological
disorders like dementia, stroke and traumatic brain injury. Cerebrolysin is a neuropeptide …

Cerebrolysin (Cere) is a compound with neurotrophic activity shown to be effective in
Alzheimer's disease in earlier trials. The efficacy and safety of three dosages of Cere were …

Cerebrolysin (Cere) is a compound with neurotrophic activity which has been shown to be
effective in the treatment of Alzheimer's disease (AD) in earlier trials. The efficacy and safety …

Summary. Cerebrolysin (Cere) is a compound with neurotrophic activity. It has been shown
to be effective in the treatment of Alzheimer's disease (AD) in earlier trials. In this multicenter …

The present study is an extension of the work of Rüther et al.(1994). 101 patients suffering
from DAT were evaluated 6 months after completion of a 4 week (5 days per week) therapy …

Traumatic brain injury (TBI) is a leading cause of death and disability for which there is
currently no effective drug therapy available. Because drugs targeting a single TBI …

Cerebrolysin is used as a neurotrophic agent for the treatment of ischemic stroke and
Alzheimer's Disease. Exploratory studies in patients with post-acute traumatic brain injury …

Cerebrolysin is a neuropeptide preparation mimicking the action of endogenous
neurotrophic factors. Positive effects of Cerebrolysin on β-amyloid-and tau-related …

The brain-derived peptidergic drug Cerebrolysin has been found to support the survival of
neurones in vitro and in vivo. Positive effects on learning and memory have been …

Abstract Background: Cerebrolysin®(Cere) is a peptidergic, neurotrophicdrug which has
been shown to improve cognitive performance and global function of Alzheimer's disease …